These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32369643)

  • 1. Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.
    Taghizadeh H; Mader RM; Müllauer L; Aust S; Polterauer S; Kölbl H; Seebacher V; Grimm C; Reinthaller A; Prager GW
    Oncologist; 2020 Jul; 25(7):e1060-e1069. PubMed ID: 32369643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applied precision cancer medicine in metastatic biliary tract cancer.
    Taghizadeh H; Müllauer L; Mader R; Prager GW
    Hepatol Int; 2020 Mar; 14(2):288-295. PubMed ID: 32100259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.
    Somasegar S; Hoppenot C; Kuchta K; Sereika A; Khandekar J; Rodriguez G; Moore E; Hurteau J; Vogel TJ
    Gynecol Oncol; 2021 Nov; 163(2):220-228. PubMed ID: 34511240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applied Precision Cancer Medicine in Neuro-Oncology.
    Taghizadeh H; Müllauer L; Furtner J; Hainfellner JA; Marosi C; Preusser M; Prager GW
    Sci Rep; 2019 Dec; 9(1):20139. PubMed ID: 31882734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applied precision medicine in metastatic pancreatic ductal adenocarcinoma.
    Taghizadeh H; Müllauer L; Mader RM; Schindl M; Prager GW
    Ther Adv Med Oncol; 2020; 12():1758835920938611. PubMed ID: 32699558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly guided treatment of metastatic parotid gland carcinoma in adults.
    Taghizadeh H; Müllauer L; Mader RM; Füreder T; Prager GW
    Wien Klin Wochenschr; 2021 Jan; 133(1-2):32-40. PubMed ID: 33296026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.
    Taghizadeh H; Zöchbauer-Müller S; Mader RM; Müllauer L; Klikovits T; Bachleitner-Hofmann T; Hoda MA; Prager GW
    Thorac Cancer; 2020 Jul; 11(7):1979-1988. PubMed ID: 32438515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.
    Rodriguez-Freixinos V; Lheureux S; Mandilaras V; Clarke B; Dhani NC; Mackay H; Butler MO; Wang L; Siu LL; Kamel-Reid S; Stockley T; Bedard PL; Oza AM
    Gynecol Oncol; 2019 May; 153(2):304-311. PubMed ID: 30792002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of a formalized precision medicine program in gynecologic oncology.
    Gunderson CC; Rowland MR; Wright DL; Andrade KL; Mannel RS; McMeekin DS; Moore KN
    Gynecol Oncol; 2016 Apr; 141(1):24-8. PubMed ID: 27016225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants.
    Nie Q; Omerza G; Chandok H; Prego M; Hsiao MC; Meyers B; Hesse A; Uvalic J; Soucy M; Bergeron D; Peracchio M; Burns S; Kelly K; Rowe S; Rueter J; Reddi HV
    Cancer Genet; 2020 Apr; 242():25-34. PubMed ID: 31992506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of gynecologic cancers and implications for clinical practice.
    Prendergast EN; Elvin JA
    Curr Opin Obstet Gynecol; 2017 Feb; 29(1):18-25. PubMed ID: 27984344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of molecular targets in vulvar cancers.
    Palisoul ML; Mullen MM; Feldman R; Thaker PH
    Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NCI-MATCH trial and precision medicine in gynecologic cancers.
    Barroilhet L; Matulonis U
    Gynecol Oncol; 2018 Mar; 148(3):585-590. PubMed ID: 29366510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.
    Kim YN; Chung YS; Lee JH; Park E; Lee ST; Kim S; Lee JY
    J Gynecol Oncol; 2023 Nov; 34(6):e70. PubMed ID: 37417298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.
    Sa JK; Hwang JR; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim J; Kim MS; Paik ES; Lee YY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee Y; Her NG; Shin YJ; Cho HJ; Kim JY; Seo YJ; Koo H; Oh JW; Lee T; Kim HS; Song SY; Bae JS; Park WY; Han HD; Ahn HJ; Sood AK; Rabadan R; Lee JK; Nam DH; Lee JW
    Genome Biol; 2019 Nov; 20(1):253. PubMed ID: 31771620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Medicine in Gynecologic Cancer: Fact or Fiction?
    Corey L; Valente A; Wade K
    Surg Oncol Clin N Am; 2020 Jan; 29(1):105-113. PubMed ID: 31757307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.
    Kraus FBT; Sultova E; Heinrich K; Jung A; Westphalen CB; Tauber CV; Kumbrink J; Rudelius M; Klauschen F; Greif PA; König A; Chelariu-Raicu A; Czogalla B; Burges A; Mahner S; Wuerstlein R; Trillsch F
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI.
    Kieler M; Unseld M; Bianconi D; Waneck F; Mader R; Wrba F; Fuereder T; Marosi C; Raderer M; Staber P; Berger W; Sibilia M; Polterauer S; Müllauer L; Preusser M; Zielinski CC; Prager GW
    ESMO Open; 2019; 4(4):e000538. PubMed ID: 31423337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.
    Dreikhausen L; Klupsch A; Wiest I; Xiao Q; Schulte N; Betge J; Boch T; Brochhausen C; Gaiser T; Hofheinz RD; Ebert M; Zhan T
    BMC Cancer; 2024 Apr; 24(1):526. PubMed ID: 38664720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Medicine for the Management of Therapy Refractory Colorectal Cancer.
    Taghizadeh H; Mader RM; Müllauer L; Erhart F; Kautzky-Willer A; Prager GW
    J Pers Med; 2020 Dec; 10(4):. PubMed ID: 33322358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.